IL33 and atopic eczema: In an atopic dermatitis-like murine model of skin inflammation, oral heat-killed YRC3780 administration alleviated allergen-induced dermal responses and decreased the expression of IL-4 and IL-33 in CD4+ T cells in the Peyer’s patches and draining lymph nodes, respectively [17].